Abstract
In recent years, prospective studies with increasing patient numbers have been published on the subject of congenital melanocytic nevi (CMN) and neurocutaneous melanocytosis (NCM). Moreover, medical experts and patient support groups have intensified their collaboration. This article summarizes current aspects of pathogenesis, clinical features, and therapy of CMN and NCM.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
